Kiobrina Uses, Dosage, Side Effects and more
Kiobrina is under investigation in clinical trial NCT00743483 (Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency).
| Attribute | Details |
|---|---|
| Trade Name | Kiobrina |
| Generic | Bucelipase alfa |
| Bucelipase alfa Other Names | rhBSSL |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
